1. Retron-Eco1 assembles NAD + -hydrolyzing filaments that provide immunity against bacteriophages.
- Author
-
Carabias A, Camara-Wilpert S, Mestre MR, Lopéz-Méndez B, Hendriks IA, Zhao R, Pape T, Fuglsang A, Luk SH, Nielsen ML, Pinilla-Redondo R, and Montoya G
- Subjects
- Hydrolysis, DNA, Single-Stranded metabolism, DNA, Single-Stranded genetics, DNA, Single-Stranded immunology, Toxin-Antitoxin Systems genetics, Escherichia coli virology, Escherichia coli genetics, Escherichia coli immunology, Escherichia coli metabolism, NAD metabolism, Cryoelectron Microscopy, Bacteriophages genetics, Bacteriophages metabolism, Bacteriophages immunology
- Abstract
Retrons are toxin-antitoxin systems protecting bacteria against bacteriophages via abortive infection. The Retron-Eco1 antitoxin is formed by a reverse transcriptase (RT) and a non-coding RNA (ncRNA)/multi-copy single-stranded DNA (msDNA) hybrid that neutralizes an uncharacterized toxic effector. Yet, the molecular mechanisms underlying phage defense remain unknown. Here, we show that the N-glycosidase effector, which belongs to the STIR superfamily, hydrolyzes NAD
+ during infection. Cryoelectron microscopy (cryo-EM) analysis shows that the msDNA stabilizes a filament that cages the effector in a low-activity state in which ADPr, a NAD+ hydrolysis product, is covalently linked to the catalytic E106 residue. Mutations shortening the msDNA induce filament disassembly and the effector's toxicity, underscoring the msDNA role in immunity. Furthermore, we discovered a phage-encoded Retron-Eco1 inhibitor (U56) that binds ADPr, highlighting the intricate interplay between retron systems and phage evolution. Our work outlines the structural basis of Retron-Eco1 defense, uncovering ADPr's pivotal role in immunity., Competing Interests: Declaration of interests G.M. is a stockholder and member of the SAB of Ensoma, and M.R.M. is listed as co-inventor of patent application WO2023141602A2, related to the use of engineered retrons for genome editing., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF